Retrospective Study
Copyright ©The Author(s) 2024.
World J Gastrointest Surg. May 27, 2024; 16(5): 1344-1353
Published online May 27, 2024. doi: 10.4240/wjgs.v16.i5.1344
Figure 1
Figure 1 Nomogram for predicting the prognosis of patients with non-metastatic colorectal cancer. CEA: Carcinoembryonic antigen; CA199: Carbohydrate antigen 19-9.
Figure 2
Figure 2 Receiver operating characteristic curves of the nomogram. A: 1-,3- and 5-year receiver operating characteristic (ROC) of nomogram using train set; B: 1-,3- and 5-year ROC of nomogram using validation set. AUC: Area under the curve.
Figure 3
Figure 3 Calibration curves for the nomogram. A: 1-,3- and 5-year calibration curves of overall survival (OS) using training set; B: 1-,3- and 5-year calibration curves of OS using validation set. OS: Overall survival.
Figure 4
Figure 4 Decision curve analysis for the nomograms. A: Decision curve analysis (DCA) of 1-year survival nomogram using training set; B: DCA of 3-year survival nomogram using training set; C: DCA of 3-year survival nomogram using training set; D: DCA of 1-year survival nomogram using validation set; E: DCA of 3-year survival nomogram using validation set; F: DCA of 5-year survival nomogram using validation set.